• Return to Headlines

Abbvie Inc Shares Down 8.1% Since SmarTrend's Sell Call (ABBV)

By Shiri Gupta

SmarTrend identified a Downtrend for Abbvie Inc (NYSE:ABBV) on January 14th, 2019 at $85.73. In approximately 4 months, Abbvie Inc has returned 8.11% as of today's recent price of $78.78.

Over the past year, Abbvie Inc has traded in a range of $75.62 to $107.25 and is now at $78.90, 4% above that low. Over the past week, the 200-day moving average (MA) has gone down 0.3% while the 50-day MA has remained constant.

AbbVie Inc. researches and develops pharmaceutical products. The Company produces pharmaceutical drugs for specialty therapeutic areas such as immunology, chronic kidney disease, hepatitis C, women's health, oncology, and neuroscience. AbbVie also offers treatments for diseases including Multiple Sclerosis, Parkinson's, and Alzheimer's disease.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Abbvie Inc.

Log in and add Abbvie Inc (ABBV) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights abbvie inc

Ticker(s): ABBV